In some respects, the mechanism of GLP-1-MK-801 is similar to other therapies targeting GLP-1 receptors, in that it activates neural circuits involved in feeding, appetite, and reward
The biggest error researchers make
Stopping the medication often leads to the return of appetite and potential weight regain
Therefore, this population might need earlier and more aggressive treatment than other groups with MASLD [56]
However, men typically have higher baseline metabolic rates and greater muscle mass, which can influence starting dose requirements and weight loss velocity compared to female patients with similar body weights
Long gone are the days when weight loss was something you had to go at alone and thank goodness for that